(Q53868318)

21 May 2018

title

Update on Therapeutic Options for Helicobacter pylori-related Diseases. (English)

1 reference

21 May 2018

0 references

1

Francis Mégraud

1 reference

21 May 2018

publication date

1 March 2005

1 reference

21 May 2018

Current infectious disease reports

published in

1 reference

21 May 2018

volume

7

1 reference

21 May 2018

issue

2

1 reference

21 May 2018

page(s)

115-120

1 reference

21 May 2018

Canadian Helicobacter pylori Consensus Conference update: infections in adults. Canadian Helicobacter Study Group

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11908-005-0071-4

Latin-American Consensus Conference on Helicobacter pylori infection. Latin-American National Gastroenterological Societies affiliated with the Inter-American Association of Gastroenterology (AIGE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-005-0071-4

How can the current strategies for Helicobacter pylori eradication therapy be improved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-005-0071-4

Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-005-0071-4

Failure of Helicobacter pylori eradication: is poor compliance the main cause?

21 January 2018

1 reference

12 December 2020

Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States

1 reference

12 December 2020

Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis

1 reference

12 December 2020

Meta-analysis: comparative efficacy of different proton-pump inhibitors in triple therapy for Helicobacter pylori eradication

1 reference

12 December 2020

A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection

1 reference

12 December 2020

Personal view: to treat or not to treat? Helicobacter pylori and gastro-oesophageal reflux disease - an alternative hypothesis

1 reference

12 December 2020

A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial

1 reference

12 December 2020

Risk factors for failure of Helicobacter pylori therapy--results of an individual data analysis of 2751 patients

1 reference

12 December 2020

Effect of different doses of furazolidone with amoxicillin and omeprazole on eradication of Helicobacter pylori

1 reference

12 December 2020

One-week omeprazole, furazolidone and amoxicillin rescue therapy after failure of Helicobacter pylori eradication with standard triple therapies

1 reference

12 December 2020

H pylori antibiotic resistance: prevalence, importance, and advances in testing

1 reference

12 December 2020

Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial

1 reference

12 December 2020

Real-time PCR assay for rapid and accurate detection of point mutations conferring resistance to clarithromycin in Helicobacter pylori

1 reference

12 December 2020

Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies

1 reference

12 December 2020

Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans

1 reference

12 December 2020

Second‐line treatment for failure to eradicate Helicobacter pylori: a randomized trial comparing four treatment strategies

1 reference

12 December 2020

Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection?

1 reference

12 December 2020

Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication

1 reference

12 December 2020

Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial

1 reference

12 December 2020

Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen

1 reference

12 December 2020

Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patien

1 reference

12 December 2020

Review article: should NSAID/low-dose aspirin takers be tested routinely for H. pylori infection and treated if positive? Implications for primary risk of ulcer and ulcer relapse after initial healing

1 reference

12 December 2020

Helicobacter pylori eradication does not exacerbate gastro-oesophageal reflux disease

1 reference

12 December 2020

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

1 reference

12 December 2020

Efficacy and safety of single-triple capsules of bismuth biskalcitrate, metronidazole and tetracycline, given with omeprazole, for the eradication of Helicobacter pylori: an international multicentre study

1 reference

12 December 2020

Pretreatment antibiotic resistance in Helicobacter pylori infection: results of three randomized controlled studies

1 reference

12 December 2020

Will eradication of Helicobacter pylori infection influence the risk of gastric cancer?

1 reference

12 December 2020

Review article: the treatment of refractory Helicobacter pylori infection

1 reference

12 December 2020

Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection

1 reference

12 December 2020

Pretreatment antimicrobial-susceptibility testing in the eradication of H. pylori infection

1 reference

12 December 2020

Rifabutin-based 'rescue therapy' for Helicobacter pylori infected patients after failure of standard regimens

1 reference

12 December 2020

Rifabutin-based triple therapy after failure of Helicobacter pylori eradication treatment: preliminary experience.

1 reference

12 December 2020

Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection

1 reference

12 December 2020

Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration

1 reference

12 December 2020

Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group

1 reference

12 December 2020

Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study

1 reference

12 December 2020

Novel real-time PCR assay for detection of Helicobacter pylori infection and simultaneous clarithromycin susceptibility testing of stool and biopsy specimens

1 reference

12 December 2020

Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori

1 reference

12 December 2020

'Rescue' therapy with rifabutin after multiple Helicobacter pylori treatment failures

1 reference

12 December 2020

Role of antibiotic sensitivity testing before first-line Helicobacter pylori eradication treatments.

1 reference

12 December 2020

Rank order of success favors longer duration of imidazole-based therapy for Helicobacter pylori in duodenal ulcer disease: a randomized pilot study

1 reference

12 December 2020

Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-1999).

1 reference

12 December 2020

10.1007/S11908-005-0071-4

Identifiers

DOI

1 reference

21 May 2018

1 reference

21 May 2018